LNSR
LENSAR IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$70.45M
P/E Ratio
—
EPS
$-0.55
Beta
0.87
52W High
$13.47
52W Low
$5.06
50-Day MA
$5.68
200-Day MA
$9.89
Dividend Yield
—
Profit Margin
50.90%
Forward P/E
—
PEG Ratio
—
About LENSAR Inc
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $57.70M |
| Gross Profit (TTM) | $26.38M |
| EBITDA | $-11.84M |
| Operating Margin | 49.20% |
| Return on Equity | 36.20% |
| Return on Assets | -14.70% |
| Revenue/Share (TTM) | $4.79 |
| Book Value | $0.89 |
| Price-to-Book | 6.38 |
| Price-to-Sales (TTM) | 1.22 |
| EV/Revenue | 1.004 |
| EV/EBITDA | -1.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -5.20% |
| Shares Outstanding | $12.10M |
| Float | $8.68M |
| % Insiders | 23.88% |
| % Institutions | 52.77% |
Historical Volatility
HV 10-Day
23.50%
HV 20-Day
35.23%
HV 30-Day
44.12%
HV 60-Day
55.83%
HV Rank
66.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.50 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026